Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Graves’ Orbitopathy: Reevaluating Rundle’s Curve
source: Thyroid
year: 2018
authors: W Pinto, D Villagelin, RB Santos, N Perini, A Fontanesi Oliveira, C Zampieri, H Paranhos Louback, L Santos Caleffi, W Muller Ferreira Tirapani, J Hamilton Romaldini
summary/abstract:Graves’ orbitopathy (GO) is the most common extrathyroidal manifestation of Graves’ disease (GD). According to Rundle’s curve, GO is characterized by an initial phase of increasing activity (inflammatory phase), a severity peak, and a stable plateau phase (fibrotic phase). This overview has an implication in GO therapeutics. Different patterns that are still distinct from Rundle’s curve have not yet been described.
There were 567 patients with GD from a single clinical center, who were analyzed according to the Clinical Activity Score (CAS) for GO activity. GO evolution was evaluated every 6 months using the CAS. The patients were divided into 2 groups according to the GO evolution: Group 1 (G1): patients who follow Rundle curve; Group 2 (G2): patients whose characteristics followed GO improvement and worsening over time. Follow-up in both groups was seen at 60 months.
From 567 initial patients, 204 patients were included. G1 (n = 132), mean (– SD), age at diagnosis was 39 – 11 years, 80% were female, with smoking present in 36% of patients. TSH and free T4 were 0.014 – 0.026 IU/mL and 4.40 – 2.09 ng/dL, respectively. Thyrotropin receptor antibodies (TRAb) were positive in 84% patients. In G2 (n = 72), age at diagnosis was 41 – 11 years, 73% were female, and smoking was present in 51% of patients. TSH and free T4 were 0.017 – 0.031 IU/mL and 3.92 – 1.82 ng/dL, respectively. TRAb were positive in 85% patients. Both groups had similar characteristics except for smoking (p < 0.05).
organization: Universidade Estadual de Campinas, BrazilDOI: 10.1089/thy.2018.29065.abstracts
read more
myBinderRelated Content
-
What Causes Bulging Eyes?Having remarkably protruding eyes disrup...
-
Glucocorticoid Regimens for Prevention of Graves’ Ophthalmopathy Progression Following Radioiodine Treatment: ...Background: Glucocorticoid (GC) therapy...
-
Management of Patients With Graves’ Orbitopathy: Initial Assessment, Management Outside Specialised Centres and Re...Graves' orbitopathy (GO) is uncommon, bu...
-
Enfermedad De Graves en Bebés Recién Nacido¿Cuáles Son las Causas de La Enfermeda...
-
Review of the Literature and Report of a Large Series of Patients Regarding the Association of Other Autoimmune Dise...Several studies have reported an associa...
-
Mayo ClinicMayo Clinic has a specialized endocrinol...
-
Michael Kazim, MDMichael Kazim is Clinical Professor of o...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Facebook
Google